With plant-based manufacturing, GSK partner Medicago takes COVID-19 vaccine production into the greenhouse

During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is hoping to repeat that magic with plant-based prophylactics.